Stanghelle B, Bentzen H, Giangregorio L, Pripp AH, Skelton DA, Bergland A.
Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial.
Osteoporos Int. 2020 Jun;31(6):1069-1078. doi: 10.1007/s00198-019-05256-4. Epub 2020 Jan 10.

Shane E, Shiau S, Recker RR, Lappe JM, Agarwal S, Kamanda-Kosseh M, Bucovsky M, Stubby J, Cohen A.
Denosumab After Teriparatide in Premenopausal Women With Idiopathic Osteoporosis.
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1528-e1540. doi: 10.1210/clinem/dgab850.

Lee JW, Kwon BC, Choi HG.
Analyses of the relationship between hyperuricemia and osteoporosis.
Sci Rep. 2021 Jun 8;11(1):12080. doi: 10.1038/s41598-021-91570-z.

Czerwinski E, Cardona J, Plebanski R, Recknor C, Vokes T, Saag KG, Binkley N, Lewiecki EM, Adachi J, Knychas D, Kendler D, Orwoll E, Chen Y, Pearman L, Li YH, Mitlak B.
The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial.
J Bone Miner Res. 2022 Dec;37(12):2435-2442. doi: 10.1002/jbmr.4719. Epub 2022 Oct 18.

Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F, Zerbini CAF, Wang Z, Oates MK, Recknor C, Libanati C.
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
J Bone Miner Res. 2021 Nov;36(11):2139-2152. doi: 10.1002/jbmr.4409. Epub 2021 Aug 10.

LeBoff MS, Chou SH, Ratliff KA, Cook NR, Khurana B, Kim E, Cawthon PM, Bauer DC, Black D, Gallagher JC, Lee IM, Buring JE, Manson JE.
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults.
N Engl J Med. 2022 Jul 28;387(4):299-309. doi: 10.1056/NEJMoa2202106.

Zhang F, Wang Z, Su H, Zhao H, Lu W, Zhou W, Zhang H.
Effect of a home-based resistance exercise program in elderly participants with osteoporosis: a randomized controlled trial.
Osteoporos Int. 2022 Sep;33(9):1937-1947. doi: 10.1007/s00198-022-06456-1. Epub 2022 Jun 15.

Stanghelle B, Bentzen H, Giangregorio L, Pripp AH, Skelton DA, Bergland A.
Physical fitness in older women with osteoporosis and vertebral fracture after a resistance and balance exercise programme: 3-month post-intervention follow-up of a randomised controlled trial.
BMC Musculoskelet Disord. 2020 Jul 18;21(1):471. doi: 10.1186/s12891-020-03495-9.

Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z.
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20.

Sølling AS, Harsløf T, Langdahl B.
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2-Year Randomized Study.
J Bone Miner Res. 2021 Jul;36(7):1245-1254. doi: 10.1002/jbmr.4305. Epub 2021 Apr 20.

Lee JW, Kwon BC, Choi HG.
Analyses of the relationship between hyperuricemia and osteoporosis.
Sci Rep. 2021 Jun 8;11(1):12080. doi: 10.1038/s41598-021-91570-z.

Stanghelle B, Bentzen H, Giangregorio L, Pripp AH, Skelton DA, Bergland A.
Physical fitness in older women with osteoporosis and vertebral fracture after a resistance and balance exercise programme: 3-month post-intervention follow-up of a randomised controlled trial.
BMC Musculoskelet Disord. 2020 Jul 18;21(1):471. doi: 10.1186/s12891-020-03495-9.

Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M.
Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
Bone. 2022 Jul;160:116416. doi: 10.1016/j.bone.2022.116416. Epub 2022 Apr 6.

Kontogeorgos G, Krantz E, Trimpou P, Laine CM, Landin-Wilhelmsen K.
Teriparatide treatment in severe osteoporosis - a controlled 10-year follow-up study.
BMC Musculoskelet Disord. 2022 Nov 24;23(1):1011. doi: 10.1186/s12891-022-05987-2.